COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Security Agreement • October 10th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October __, 2014 (the “Issuance Date”) and on or prior to the close of business on October __, 2017 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided, however, to the extent that a resale registration statement registering all of the Warrant Shares (the “Resale Registration Statement”) is not filed within 30 days of the Issuance Date, is not declared effective within 90 days of the Issuance Date or is suspended for any reason thereafter prior to the Termination Date, the Termination Date shall be extended by an equ
STOCK PURCHASE, AMENDMENT AND ISSUANCE AGREEMENTStock Purchase Agreement • October 10th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
This Amendment and Issuance Agreement (the “Agreement”), dated as of October 6, 2014, is by and among Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of those certain rights to purchase additional shares of Common Stock pursuant to Section 2.2 of the Securities Purchase Agreement (“Purchase Agreement”), dated April 9, 2014, by and among the Company and the Holder (“Overallotment Right”).
STRICTLY CONFIDENTIALEngagement Agreement • October 10th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
